Thermo Fisher Scientific Inc. (TMO) research: valuation against peers, fundamentals over time, risk and news coverage
TMO
Thermo Fisher Scientific Inc.No data in this window.
Every report in our own archive tagged with this symbol, newest first — fetched from the archive alongside the market data.
- MARKET REPORTNEUTRALCarlyle, First Citizens Hit 52-Week Lows as Thermo Fisher, Agilent Hit Highs
Carlyle Group fell to a 52-week low of $39.15 and First Citizens BancShares to $19.56, while Thermo Fisher Scientific hit a 52-week high of $671.69 and Xometry an all-time high of $107.00.
- SPECIAL REPORTBEARISHInsider Selling Wave Sweeps US Corporates as Executives Cash Out Across Tech, Healthcare and Media
A dense cluster of insider disposals spanning Thermo Fisher, Block, Magnite, Colgate-Palmolive, IFF, Aurora Innovation, Tenet Healthcare, Accel Entertainment, Cohen & Co, Gevo and Warner Bros. Discovery signals executives are trimming exposure after a powerful equity run. While individually routine, the aggregate pattern is a classic late-cycle tell.
Every figure on this page is fetched and computed in your browser from free public sources — end-of-day prices and reported financials from Yahoo Finance's open endpoints, and our own archive for the coverage panel. Fundamental history on the free tier runs about four fiscal years and five quarters. Data is best-effort and unaudited; this is market research, not investment advice.
Only 0 resolved quarters on record — below the 6-period threshold, so no verdict is published.
n = 0 resolved forecasts · 14 on record, none yet resolved
Insufficient sample — no verdict published. TMO has 0 resolved forecasts on record, below the 6 needed before we will characterise a management team’s forecasting. The record below is published in full; the company is excluded from every ranking on this site until it clears the threshold.
Next report expected 21 Oct 2026 (Q3 FY2026) — Estimated from the issuer's own filing history: FY2025Q3 results were released on 2025-10-22. source
| Period | Measure | Guided | Issued | Reported | Landed | Deviation | Verdict | Sources |
|---|---|---|---|---|---|---|---|---|
| FY 2024revised | Revenue | $42.40–$43.30bn | 2024-10-23 | — | — | — | PENDING | guidance |
| “Revenue guidance continues to be in the range of $42.4 to $43.3 billion.” | ||||||||
| FY 2024revised | EPS (adj.) | $21.35–$22.07 | 2024-10-23 | — | — | — | PENDING | guidance |
| “Thermo Fisher is raising its full-year adjusted EPS guidance to a new range of $21.35 to $22.07 versus its previous guidance of $21.29 to $22.07.” | ||||||||
| FY 2024revised | EPS (adj.) | $21.29–$22.07 | 2024-07-24 | — | — | — | PENDING | guidance |
| “The company is raising its adjusted EPS guidance to a new range of $21.29 to $22.07 versus its previous guidance of $21.14 to $22.02.” | ||||||||
| FY 2024revised | Revenue | $42.40–$43.30bn | 2024-07-24 | — | — | — | PENDING | guidance |
| “The company is raising its revenue guidance to a new range of $42.4 to $43.3 billion versus its previous guidance of $42.3 to $43.3 billion.” | ||||||||
| FY 2024revised | EPS (adj.) | $21.14–$22.02 | 2024-04-24 | — | — | — | PENDING | guidance |
| “The company is raising its adjusted EPS guidance to a new range of $21.14 to $22.02 versus its previous guidance of $20.95 to $22.00.” | ||||||||
| FY 2024revised | Revenue | $42.30–$43.30bn | 2024-04-24 | — | — | — | PENDING | guidance |
| “The company is raising its revenue guidance to a new range of $42.3 to $43.3 billion versus its previous guidance of $42.1 to $43.3 billion.” | ||||||||
| FY 2024 | EPS (adj.) | $20.95–$22.00 | 2024-01-31 | — | — | — | PENDING | guidance |
| “Thermo Fisher is initiating a guidance range for full year 2024 with revenue of $42.1 billion to $43.3 billion and adjusted EPS of $20.95 to $22.00.” | ||||||||
| FY 2024 | Revenue | $42.10–$43.30bn | 2024-01-31 | — | — | — | PENDING | guidance |
| “Thermo Fisher is initiating a guidance range for full year 2024 with revenue of $42.1 billion to $43.3 billion and adjusted EPS of $20.95 to $22.00.” | ||||||||
| FY 2023revised | EPS (adj.) | $21.50 | 2023-10-25 | — | — | — | PENDING | guidance |
| “The company now expects 2023 revenue to be $42.7 billion, with Core organic revenue growth of 1%, and adjusted EPS of $21.50.” | ||||||||
| FY 2023revised | Revenue | $42.7bn | 2023-10-25 | — | — | — | PENDING | guidance |
| “The company now expects 2023 revenue to be $42.7 billion, with Core organic revenue growth of 1%, and adjusted EPS of $21.50.” | ||||||||
| FY 2023revised | EPS (adj.) | $22.28–$22.72 | 2023-07-26 | — | — | — | PENDING | guidance |
| “The company now expects 2023 revenue to be a range of $43.4 to $44.0 billion, with Core organic revenue growth of 2 to 4%, and adjusted EPS of $22.28 to $22.72.” | ||||||||
| FY 2023revised | Revenue | $43.40–$44.00bn | 2023-07-26 | — | — | — | PENDING | guidance |
| “The company now expects 2023 revenue to be a range of $43.4 to $44.0 billion, with Core organic revenue growth of 2 to 4%, and adjusted EPS of $22.28 to $22.72.” | ||||||||
| FY 2023 | EPS (adj.) | $23.70 | 2023-02-01 | — | — | — | PENDING | guidance |
| “The company expects to achieve adjusted EPS of $23.70.” | ||||||||
| FY 2023 | Revenue | $45.3bn | 2023-02-01 | — | — | — | PENDING | guidance |
| “The company expects to achieve 2023 revenue of $45.3 billion and full year Core organic revenue growth of 7%.” | ||||||||
Every figure above is read from the company’s own filings. “Guidance” links to the 8-K exhibit that issued the forecast; “result” links to the exhibit in which the company reported the outcome. Nothing here is an analyst estimate. How this is measured.